Jeff Landau

Jeff Landau

Senior Vice President and Chief Business OfficeratCytomX Therapeutics· In proxies 2022–2023

Pay in FY2023-1% from the year before · CytomX Therapeutics stock -3.1% the same year

Jeff Landau was paid $1.0M in FY2023 (Dec), down 1%. CytomX Therapeutics stock fell 3.1% that year.

Pay$100 in the stock at the end of FY21 → $36
Pay is from the Summary Compensation Table of each CytomX Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytomX TherapeuticsPublic company · 4 yr
    • Senior Vice President and Chief Business Officer2022 – Present · 4 yrStock in role -44%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?